{
    "code": "10000879",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000879",
    "time": "2022-11-18 06:24:25",
    "許可證字號": "衛署菌疫輸字第000879號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/03\/30",
    "發證日期": "98\/03\/30",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000087905",
    "中文品名": "樂舒晴注射劑 10 毫克\/毫升",
    "英文品名": "Lucentis 10mg\/ml solution for injection",
    "適應症": "成人：\r\n(1) 治療脈絡膜血管新生(choroidal neovascularization , CNV)所導致的視力損害。(2) 治療血管新生型(濕性)年齡相關性黃斑部退化病變(age-related macular degeneration, AMD)。(3) 治療糖尿病引起黃斑部水腫(diabetic macular edema, DME)所導致的視力損害。(4) 治療視網膜靜脈阻塞(分支或中央視網膜靜脈阻塞；branch or central retinal vein occlusion； BRVO 或 CRVO) 續發黃斑部水腫所導致的視力損害 (5) 治療中重度非增殖性糖尿病視網膜病變(moderately severe or severe non-proliferative diabetic retinopathy, NPDR)及增殖性糖尿病視網膜病變(proliferative diabetic retinopathy, PDR)。\r\n早產兒：早產兒視網膜病變(Retinopathy of prematurity, ROP)",
    "劑型": "270注射劑",
    "包裝": "0.23毫升、0.3毫升瓶裝附注射針筒、針頭、過濾針頭 0.23毫升瓶裝附過濾針頭小瓶附溶液及過濾針頭 0.23毫升瓶裝瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "RANIBIZUMAB",
    "限制項目": "02輸　入",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0088000  NOVARTIS PHARMA STEIN AG",
            "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0088200  NOVARTIS PHARMA. AG",
            "製造廠廠址": "LICHTSTRASSE 35 CH-4056 BASLE, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        },
        {
            "製造廠名稱": "FSG0030000  Roche Singapore Technical Operations Pte.Ltd.",
            "製造廠廠址": "10 Tuas Bay Link, 637394 Singapore",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013002100",
            "成分名稱": "RANIBIZUMAB",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "000879_Lucentis solution for injection 10mgml-108-06-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000879&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lucentis-TWI-270320 (005)-109-05-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000879&Seq=018&Type=9"
        },
        {
            "title": "109.4.27 Lucentis-TWI-270320 (004)-109-04-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000879&Seq=017&Type=9"
        },
        {
            "title": "7-1_2159466_U17_p1_LBL_X-4-107-10-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000879&Seq=002&Type=8"
        },
        {
            "title": "7-2_2183175_TW_p2_FB_X-4-107-10-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000879&Seq=001&Type=8"
        }
    ]
}